专题:中医药传承与临床实践

近20年中医药临床研究创新发展

  • 陶立元 ,
  • 冯玉婷 ,
  • 商洪才
展开
  • 1. 北京中医药大学东直门医院, 北京 100700;
    2. 北京大学第三医院临床流行病学研究中心, 北京 100191;
    3. 北京中医药大学中医学院, 北京 100029
陶立元,副研究员,研究方向为中医药疗效评价方法、公共卫生方法学,电子信箱: tendytly@163.com

收稿日期: 2022-09-01

  修回日期: 2022-10-20

  网络出版日期: 2022-12-12

基金资助

国家自然科学基金项目(82004210)

Analysis on innovation and development of clinical research of traditional Chinese medicine in the past 20 years

  • TAO Liyuan ,
  • FENG Yuting ,
  • SHANG Hongcai
Expand
  • 1. Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China;
    2. Clinical Epidemiology Research Center of the Third Hospital of Peking University, Beijing 100191, China;
    3. College of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing 100029, China

Received date: 2022-09-01

  Revised date: 2022-10-20

  Online published: 2022-12-12

摘要

分析了近20年来中国中医药传承创新方面的科研进展,包括近20年国内外中医药临床注册研究进展、中国中医药在治疗传染性疾病及慢性非传染性疾病方面的临床研究进展、中医药标准化研究及应用进展、新技术在中医药研究中的应用进展,以及“一带一路”促进中国中医药临床研究发展。分析表明,近20年来的中国中医药临床研究创新成果为中医药传承创新发展提供了重要的科技保障,中医药历史性地进入了世界主流医学体系,其国际影响力正在显著提升。

本文引用格式

陶立元 , 冯玉婷 , 商洪才 . 近20年中医药临床研究创新发展[J]. 科技导报, 2022 , 40(23) : 24 -29 . DOI: 10.3981/j.issn.1000-7857.2022.23.002

Abstract

In response to the "Traditional Chinese Medicine Development Plan" of the Fourteenth Five Year Development Plan, and to strengthen the departmental development of traditional Chinese medicine and clinical research, this paper systematically analyzes the scientific research progress in the inheritance and innovation of Chinese medicine in the past 20 years. The contents, include the research progress in clinical registration of traditional Chinese medicine at home and abroad in the past 20 years, the clinical research progress in the treatment of infectious diseases and chronic non infectious diseases, research and application progress of standardization of traditional Chinese medicine, research and application progress of new technologies in traditional Chinese medicine, and the "the Belt and Road Initiative" promoting the development of clinical research of traditional Chinese medicine in China. The results show that the clinical research and innovation achievements of Chinese medicine in the past 20 years have provided an important scientific and technological guarantee for inheritance, innovation and development of Chinese medicine. Chinese medicine has historically entered the mainstream medical system in the world and its international influence is significantly improving.

参考文献

[1] 中共中央国务院关于促进中医药传承创新发展的意见[EB/OL].(2019-10-26)[2022-10-01]. http://www.gov.cn/zhengce/2019-10/26/content_5445336.htm.
[2] 国家中医药管理局.国家中医药管理局解读《"十四五"中医药发展规划》[EB/OL].(2022-03-29)[2022-10-01]. http://gcs.satcm.gov.cn/zhengcewenjian/2022-03-29/2569-5.html.
[3] 国务院办公厅.关于印发"十四五"中医药发展规划的通知[EB/OL].(2022-03-29)[2022-10-01]. http://www.satcm.gov.cn/guicaisi/zhengcewenjian/2022-03-29/25694.html.
[4] Cyranoski D. Why Chinese medicine is heading for clinics around the world[J]. Nature, 2018, 561(7724):448-450.
[5] Fears R, Griffin G E, Larhammar D, et al. Globalization of traditional Chinese medicine:What are the issues for ensuring evidence-based diagnosis and therapy[J]. Journal of Internal Medicine, 2020, 287(2):210-213.
[6] NIH National Center for Complementary and Integrative Health. Traditional Chinese Medicine:What you need to know[EB/OL].[2022-10-01]. https://nccih.nih.gov/health/whatiscam/chinesemed.html.
[7] Kemppainen L M, Kemppainen T T, Reippainen J A, et al. Use of complementary and alternative medicine in Europe:Health-related and sociodemographic determinants[J]. Scandinavian Journal of Public Health, 2018, 46(4):448-455.
[8] 中华中医药学会. 2020年度中医药十大学术进展[EB/OL].(2021-03-07)[2022-10-01]. http://www.satcm.gov.cn/hudongjiaoliu/guanfangweixin/2021-03-07/20626.html.
[9] Hu K, Guan W, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019:A multicenter, prospective, randomized controlled trial[J]. Phytomedicine, 2021, 85:153242.
[10] Liang S, Fang M, Liang C, et al. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19:A rapid systematic review and meta-analysis of randomized controlled trials[J]. Complementary Therapies in Medicine, 2021, 60:102744.
[11] 国家中医药管理局.重磅!2021年度中医药十大学术进展发布[EB/OL].(2022-01-13)[2022-10-01]. http://www.satcm.gov.cn/e/search/result/?searchid=51609.
[12] Lu L, Zhang Y, Tang X, et al. A neuroanatomical basis for electroacupuncture to drive the vagal-adrenal axis[J]. Nature, 2021, 598(7882):641-645.
[13] Lu L, Zhang Y, Tang X, et al. Evidence on acupuncture therapies is underused in clinical practice and health policy[J]. British Medical Journal, 2022, 376:e067475.
[14] Sun Y, Liu Y, Liu B, et al. Efficacy of acupuncture for chronic prostatitis/chronic pelvic pain syndrome:A Randomized Trial[J]. Annals of Internal Medicine, 2021,174(10):1357-1366.
[15] Xu S, Yu L, Luo X, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura:Multicentre, randomised clinical trial[J]. British Medical Journal, 2020, 368:m697.
[16] Qaseem A, Wilt T J, McLean R M, et al. Noninvasive treatments for acute, subacute, and chronic low back pain:A clinical practice guideline from the American college of physicians[J]. Annals of Internal Medicine, 2017, 166(7):514-530.
[17] 于博,陈方,杨阿强."一带一路"空间减灾研究与发展[J].科技导报, 2020, 38(16):53-57.
[18] 国家中医药管理局推进"一带一路"建设工作领导小组办公室.关于印发《推进中医药高质量融入共建"一带一路"发展规划(2021-2025年)》的通知[EB/OL].(2022-01-15)[2022-10-01]. http://ghs.satcm.gov.cn/zhengcewenjian/2022-01-15/24182.html.
文章导航

/